Education
About Us
Working with TipRanks
Follow Us
Shoulder Innovations, Inc. (SI)
NYSE:SI
Top Page
Shoulder Innovations, Inc.
(NYSE:SI)
Select Model
Select Model
Rating:41Neutral
Price Target:
$11.50
▼(-4.96% Downside)
The overall stock score for Shoulder Innovations, Inc. is primarily impacted by its financial performance, which shows revenue growth but significant profitability and cash flow challenges. Technical analysis indicates bearish momentum, and the valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively suggest caution for potential investors.
Positive Factors
Revenue Growth
Strong revenue growth indicates successful market penetration and increasing demand for SI's orthopedic solutions, supporting long-term expansion.
Business Model
The direct sales model, combined with strategic partnerships, enhances market reach and customer engagement, fostering sustainable revenue streams.
Product Innovation
SI's focus on innovative products for minimally invasive procedures positions it as a leader in orthopedic solutions, driving competitive advantage.
Negative Factors
Profitability Challenges
Ongoing profitability challenges, with negative margins, could hinder reinvestment and growth, impacting long-term financial health.
Cash Flow Issues
Negative operational cash flow raises concerns about liquidity and the ability to fund operations without external financing.
Increased Leverage
Rising leverage could strain financial flexibility and increase risk, especially if revenue growth does not translate into improved profitability.
Shoulder Innovations, Inc. (SI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)165.08K
Price to Earnings (P/E)―
Beta (1Y)-1.66
Revenue Growth39.77%
EPS Growth-122.70%
CountryUS
Employees300
SectorHealthcare
Sector Strength45
IndustryMedical - Specialties
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,359,960
10 Day Avg. Volume193,565
30 Day Avg. Volume165,082
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.39Price Target Upside43.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Shoulder Innovations, Inc. Business Overview & Revenue Model
Company DescriptionShoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
How the Company Makes MoneyShoulder Innovations, Inc. generates revenue primarily through the sale of its orthopedic surgical products, including implants and instruments used in shoulder surgeries. The company utilizes a direct sales model, partnering with hospitals, surgical centers, and orthopedic surgeons to provide its products. Additionally, SI may engage in strategic partnerships with larger medical device companies to expand its distribution channels and market reach. Revenue is also supplemented through training programs for surgical staff and ongoing support services, ensuring that healthcare providers are well equipped to use SI's products effectively.
Shoulder Innovations, Inc. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
50
Neutral
Cash Flow
40
Negative
| Breakdown | Dec 2024 | Dec 2023 |
|---|---|---|
Income Statement | ||
| Total Revenue | 31.62M | 19.27M |
| Gross Profit | 24.34M | 15.27M |
| EBITDA | -12.76M | -9.52M |
| Net Income | -15.62M | -12.65M |
Balance Sheet | ||
| Total Assets | 43.08M | 54.29M |
| Cash, Cash Equivalents and Short-Term Investments | 15.04M | 32.81M |
| Total Debt | 14.73M | 14.46M |
| Total Liabilities | 22.33M | 18.70M |
| Stockholders Equity | 20.75M | 35.59M |
Cash Flow | ||
| Free Cash Flow | -18.16M | -15.89M |
| Operating Cash Flow | -14.14M | -13.14M |
| Investing Cash Flow | 13.96M | -28.97M |
| Financing Cash Flow | 66.00K | 44.73M |
Shoulder Innovations, Inc. Risk Analysis
Shoulder Innovations, Inc. disclosed 44 risk factors in its most recent earnings report. Shoulder Innovations, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Shoulder Innovations, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.